Our day will come, be patient.22 Apr 2020 21:12
Covid will no doubt have slowed operations down in Japan. Like here, offices are closed and people are trying to avoid the disease. I think this will likely mean a conclusion/deal on nxp002 in H2. By this time our share price should have improved and the bounce will be higher.
I will continue to buy as I can and hope to do this for a few months. Anything under 10p i believe is a bargain.
So, to the doubters - just hang on in there. If you dont believe the patents, the runway of products , the fact we dont need to do any more cash raises, the Ebers deal payments due in H1 and beyond, Kissei deal impending (once covid allows us to relax a bit and is totally OUT OF THE BOD's control), the Chinese money that will come (eventually)....then you shouldnt be invested here.
I cant see there being a consistent sp rise until June so if you are here for a quick trade you might have more of a wait.
I am here like others for the end game. A sale of the business to a massive pharma company. Our patents will be worth a pretty penny - hopefully £1 and beyond. This mag be 5 years away so takes a healthy dose of patience.